Seeking Alpha

  Sarepta Therapeutics, Inc. - NASDAQ

11/1/2014, 1:36 AM ET
  • StockConsultant | Send Message 13 Jan

    $SRPT strong, coming up to a price gap breakout above 21.37, volume +34% normal,
      SRPT vs. ETF Alternatives
      Company Description
      Sarepta Therapeutics Inc discovers and develops RNA-based therapeutics for the treatment of rare and infectious diseases. Its product candidates include eteplirsen, AVI-6002, AVI-6003, and AVI-7100.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States